Page last updated: 2024-08-23

tetradecanoylphorbol acetate and Acute Relapsing Multiple Sclerosis

tetradecanoylphorbol acetate has been researched along with Acute Relapsing Multiple Sclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hestvik, AL; Holmøy, T; Høglund, RA; Maghazachi, AA1
Gata, JM; Izquierdo, G; Lucas, M; Rodríguez, MC; Solano, F; Zayas, MD1

Other Studies

2 other study(ies) available for tetradecanoylphorbol acetate and Acute Relapsing Multiple Sclerosis

ArticleYear
Expression and functional activity of chemokine receptors in glatiramer acetate-specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate.
    Human immunology, 2011, Volume: 72, Issue:2

    Topics: Adult; Blood; CD4-Positive T-Lymphocytes; Cell Movement; Cells, Cultured; Cerebrospinal Fluid; Chemokines; Chemotaxis, Leukocyte; Flow Cytometry; Gene Expression; Glatiramer Acetate; Humans; Inflammation; Ionomycin; Lymphocyte Activation; Male; Multiple Sclerosis, Relapsing-Remitting; Peptides; Receptors, CCR4; Receptors, CCR5; Receptors, CCR6; Receptors, CXCR3; Signal Transduction; Tetradecanoylphorbol Acetate

2011
Regulation by interferon beta-1a of reactive oxygen metabolites production by lymphocytes and monocytes and serum sulfhydryls in relapsing multiple sclerosis patients.
    Neurochemistry international, 2003, Volume: 42, Issue:1

    Topics: Adult; Dithionitrobenzoic Acid; Female; Free Radicals; Humans; Interferon beta-1a; Interferon-beta; Lymphocytes; Male; Middle Aged; Monocytes; Multiple Sclerosis, Relapsing-Remitting; Oxidation-Reduction; Reactive Oxygen Species; Sulfhydryl Compounds; Tetradecanoylphorbol Acetate

2003